Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Bac Nguyen Hoai, Long Hoang, Thang Nguyen Cao, Quan Pham Minh & Emmanuele A. Jannini. (2023) Testosterone and aging male, a perspective from a developing country. The Aging Male 26:1.
Read now
Read now
Bernice Asiedu, Yvonne Anang, Adraina Nyarko, Derek Amartey Doku, Brodrick Y. Amoah, Sheila Santa, Robert A. Ngala & George A. Asare. (2017) The role of sex steroid hormones in benign prostatic hyperplasia. The Aging Male 20:1, pages 17-22.
Read now
Read now
Aydogan Aydogdu & Ronald S. Swerdloff. (2016) Emerging medication for the treatment of male hypogonadism. Expert Opinion on Emerging Drugs 21:3, pages 255-266.
Read now
Read now
Gary Blick. (2013) Optimal Diagnostic Measures and Thresholds for Hypogonadism in Men With HIV/AIDS: Comparison Between 2 Transdermal Testosterone Replacement Therapy Gels. Postgraduate Medicine 125:2, pages 30-39.
Read now
Read now
Nazem Bassil, Saad Alkaade & John E Morley. (2009) The benefits and risks of testosterone replacement therapy: a review. Therapeutics and Clinical Risk Management 5, pages 427-448.
Read now
Read now
Ingo Alberti, Arnaud Grenier, Holger Kraus & Dario Norberto Carrara. (2005) Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery. Expert Opinion on Drug Delivery 2:5, pages 935-950.
Read now
Read now
SM Harman. (2005) Testosterone in older men after the Institute of Medicine Report: where do we go from here?. Climacteric 8:2, pages 124-135.
Read now
Read now
T Ebert. (2004) Clinical experiences with testosterone therapy: prostate safety. The Aging Male 7:4, pages 304-311.
Read now
Read now
Articles from other publishers (28)
Joshua White, Francis Petrella & Jesse Ory. (2022) Testosterone therapy and secondary erythrocytosis. International Journal of Impotence Research 34:7, pages 693-697.
Crossref
Crossref
Milou Cecilia Madsen, Martin den Heijer, Claudia Pees, Nienke R Biermasz & Leontine E H Bakker. (2022) Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations. Endocrine Connections 11:8.
Crossref
Crossref
Sandro La Vignera, Giulia Izzo, Gian Pietro Emerenziani, Rossella Cannarella, Rosita A. Condorelli, Aldo E. Calogero & Antonio Aversa. (2020) Male hypogonadism: therapeutic choices and pharmacological management. Minerva Endocrinologica 45:3.
Crossref
Crossref
Yu Seob Shin & Jong Kwan Park. (2019) The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism. Journal of Clinical Medicine 8:2, pages 209.
Crossref
Crossref
Samuel J. Ohlander, Bibin Varghese & Alexander W. Pastuszak. (2018) Erythrocytosis Following Testosterone Therapy. Sexual Medicine Reviews 6:1, pages 77-85.
Crossref
Crossref
Mohit Khera, Gregory A. Broderick, Culley C. CarsonIIIIII, Adrian S. Dobs, Martha M. Faraday, Irwin Goldstein, Lawrence S. Hakim, Wayne J.G. Hellstrom, Ravi Kacker, Tobias S. Köhler, Jesse N. Mills, Martin Miner, Hossein Sadeghi-Nejad, Allen D. Seftel, Ira D. Sharlip, Stephen J. Winters & Arthur L. Burnett. (2016) Adult-Onset Hypogonadism. Mayo Clinic Proceedings 91:7, pages 908-926.
Crossref
Crossref
Jacques Baillargeon, Randall J. Urban, Abraham Morgentaler, Charles J. Glueck, Gwen Baillargeon, Gulshan Sharma & Yong-Fang Kuo. (2015) Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy. Mayo Clinic Proceedings 90:8, pages 1038-1045.
Crossref
Crossref
Steven D. JonesJr.Jr., Thomas Dukovac, Premsant Sangkum, Faysal A. Yafi & Wayne J.G. Hellstrom. (2015) Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male. Sexual Medicine Reviews 3:2, pages 101-112.
Crossref
Crossref
Jacques Baillargeon, Randall J. Urban, Yong-Fang Kuo, Holly M. Holmes, Mukaila A. Raji, Abraham Morgentaler, Bret T. Howrey, Yu-Li Lin & Kenneth J. Ottenbacher. (2015) Screening and Monitoring in Men Prescribed Testosterone Therapy in the U.S., 2001–2010. Public Health Reports 130:2, pages 143-152.
Crossref
Crossref
S. Larry Goldenberg, Anthony Koupparis & Michael E. Robinson. (2011) Differing levels of testosterone and the prostate: a physiological interplay. Nature Reviews Urology 8:7, pages 365-377.
Crossref
Crossref
Farid Saad, Ahmad Haider, Erik J. Giltay & Louis J.G. Gooren. (2011) Age, obesity and inflammation at baseline predict the effects of testosterone administration on the metabolic syndrome. Hormone Molecular Biology and Clinical Investigation 6:1.
Crossref
Crossref
Robert J. Feeley, Farid Saad, Andre Guay & Abdulmaged M. Traish. (2009) Testosterone in men's health: a new role for an old hormone. Journal of Men's Health 6:3, pages 169-176.
Crossref
Crossref
Bruno LunenfeldMichael Oettel. (2009) Therapeutic potential of testosterone gels. Aging Health 5:2, pages 227-245.
Crossref
Crossref
Harald Jörn Schneider, Caroline Sievers, Jens Klotsche, Steffen Böhler, David Pittrow, Hendrik Lehnert, Hans-Ulrich Wittchen & Günter Karl Stalla. (2009) Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study. Clinical Endocrinology 70:3, pages 446-454.
Crossref
Crossref
R Shabsigh, E D Crawford, A Nehra & K M Slawin. (2008) Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. International Journal of Impotence Research 21:1, pages 9-23.
Crossref
Crossref
Drew McLaren, D. Robert Siemens, Jason Izard, Angela Black & Alvaro Morales. (2008) Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome. BJU International 102:9, pages 1142-1146.
Crossref
Crossref
L. J. Gooren, F. Saad, A. Haide & A. Yassin. (2008) Decline of plasma 5α-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels. Andrologia 40:5, pages 298-302.
Crossref
Crossref
Timothy C. Brand, Edith Canby-Hagino & Ian M. Thompson. (2008) Testosterone replacement therapy and prostate cancer: A word of caution. Current Sexual Health Reports 5:1, pages 31-35.
Crossref
Crossref
Aksam A. Yassin. (2007) The role for intramuscular testosterone injection in the gel era. Current Sexual Health Reports 4:3, pages 125-130.
Crossref
Crossref
H S Chiang, T I S Hwang, Y S Hsui, Y C Lin, H E Chen, G C Chen & C H Liao. (2007) Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function. International Journal of Impotence Research 19:4, pages 411-417.
Crossref
Crossref
Timothy C. Brand, Edith Canby-Hagino & Ian M. Thompson. (2007) Testosterone replacement therapy and prostate cancer: A word of caution. Current Urology Reports 8:3, pages 185-189.
Crossref
Crossref
Upendram Srinivas-Shankar & Frederick CW Wu. (2006) Drug Insight: testosterone preparations. Nature Clinical Practice Urology 3:12, pages 653-665.
Crossref
Crossref
John B. Kostis, Graham Jackson, Raymond Rosen, Elizabeth Barrett-Connor, Kevin Billups, Arthur L. Burnett, Culley CarsonIIIIII, Melvin Cheitlin, Robert Debusk, Vivian Fonseca, Peter Ganz, Irwin Goldstein, Andre Guay, Dimitris Hatzichristou, Judd E. Hollander, Adolph Hutter, Stuart Katz, Robert A. Kloner, Murray Mittleman, Francesco Montorsi, Piero Montorsi, Ajay Nehra, Richard Sadovsky & Ridwan Shabsigh. (2005) Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference). The American Journal of Cardiology 96:12, pages 85-93.
Crossref
Crossref
Jean M. Kaufman & Alex Vermeulen. (2005) The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications. Endocrine Reviews 26:6, pages 833-876.
Crossref
Crossref
John B. Kostis, Graham Jackson, Raymond Rosen, Elizabeth Barrett-Connor, Kevin Billups, Arthur L. Burnett, Culley CarsonIIIIII, Melvin Cheitlin, Robert Debusk, Vivian Fonseca, Peter Ganz, Irwin Goldstein, Andre Guay, Dimitris Hatzichristou, Judd E. Hollander, Adolph Hutter, Stuart Katz, Robert A. Kloner, Murray Mittleman, Francesco Montorsi, Piero Montorsi, Ajay Nehra, Richard Sadovsky & Ridwan Shabsigh. (2005) Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference). The American Journal of Cardiology 96:2, pages 313-321.
Crossref
Crossref
Alvaro Morales. (2004) Testosterone treatment for the aging man: The controversy. Current Urology Reports 5:6, pages 472-477.
Crossref
Crossref
Abraham Morgentaler. (2004) Testosterone replacement therapy: Benefits, risks, and controversies. Current Sexual Health Reports 1:2, pages 67-71.
Crossref
Crossref
Kassandra L. Edinger & Cheryl A. Frye. (2004) Testosterone's Analgesic, Anxiolytic, and Cognitive-Enhancing Effects May Be Due in Part to Actions of Its 5α-Reduced Metabolites in the Hippocampus.. Behavioral Neuroscience 118:6, pages 1352-1364.
Crossref
Crossref